Welcome to the international HTA database

Showing [16861 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	National Institute for Health and Care Excellence (NICE)	The ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation after burn injury. NICE medical technologies guidance 21
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for hepatitis B virus infection in nonpregnant adolescents and adults: systematic review to update the 2004 U.S. Preventive Services Task Force Recommendation
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Pesky gNATs cognitive behaviour therapy for children with anxiety and low mood
2014	NIHR Health Services and Delivery Research programme	Specialist rehabilitation for people with Parkinson's disease in the community: a randomised controlled trial
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intravenous infusion pumps for transfusion of blood products: clinical effectiveness and guidelines
2014	National Institute for Health and Care Excellence (NICE)	Insertion of a collagen plug to close an abdominal wall enterocutaneous fistula. NICE interventional procedures guidance 507
2014	National Institute for Health and Care Excellence (NICE)	The geko device for reducing the risk of venous thromboembolism. NICE medical technologies guidance 19
2014	Health Quality Ontario (HQO)	The appropriate use of neuroimaging in the diagnostic work-up of dementia: an evidence-based analysis
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Abaloparatide for postmenopausal osteoporosis – first and second line
2014	Blue Cross Blue Shield Association (BCBS)	Quantitative electroencephalography as a diagnostic aid for attention-deficit/hyperactivity disorder in children
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Foot care for seniors in the community setting: clinical effectiveness and guidelines
2014	National Institute for Health and Care Excellence (NICE)	Combined endoscopic and laparoscopic removal of colonic polyps. NICE interventional procedures guidance 503
2014	Health Quality Ontario (HQO)	The appropriate use of neuroimaging in the diagnostic work-up of dementia: an economic literature review and cost-effectiveness analysis
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Idalopirdine for Alzheimer's disease as an adjunct to acetylcholinesterase inhibitor therapy
2014	Blue Cross Blue Shield Association (BCBS)	Critical issues in robotic surgery
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Techniques and products for surgical hand antisepsis: a review of guidelines
2014	National Institute for Health and Care Excellence (NICE)	Total prosthetic replacement of the temporomandibular joint. NICE interventional procedures guidance 500
2014	Health Quality Ontario (HQO)	Multiple intravenous infusions phase 2b: laboratory study
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Pimavanserin tartrate for psychosis associated with Parkinson's disease - first line
2014	Blue Cross Blue Shield Association (BCBS)	Gene expression profiling in women with lymph node‒negative breast cancer to select adjuvant chemotherapy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Obesity management interventions delivered in primary care for patients with hypertension or cardiovascular disease: a review of clinical effectiveness
2014	National Institute for Health and Care Excellence (NICE)	Minimally invasive video-assisted thyroidectomy. NICE interventional procedures guidance 499
2014	Health Quality Ontario (HQO)	Multiple intravenous infusions phase 2a: Ontario survey
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Daclizumab High Yield Process for relapsing forms of multiple sclerosis – first or second line
2014	Blue Cross Blue Shield Association (BCBS)	Percutaneous mitral valve repair
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Combination use of insulin and fipeptidyl peptidase-4 (DDP-4) inhibitors in Type 2 diabetes: clinical effectiveness
2014	National Institute for Health and Care Excellence (NICE)	Minimally invasive video-assisted parathyroidectomy. NICE interventional procedures guidance 501
2014	Health Quality Ontario (HQO)	Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study
2014	Blue Cross Blue Shield Association (BCBS)	Use of digital breast tomosynthesis with mammography for breast cancer screening or diagnosis
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Fingolimod for chronic inflammatory demyelinating polyneuropathy – second line
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Retrieval and redistribution of unused home care supplies: safety, cost-effectiveness, and guidelines
2014	National Institute for Health and Care Excellence (NICE)	Assessing motility of the gastrointestinal tract using a wireless capsule. NICE interventional procedures guidance 502
2014	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds
2014	Health Quality Ontario (HQO)	Frequency of testing for dyslipidemia: an evidence-based analysis
2014	Blue Cross Blue Shield Association (BCBS)	Artificial lumbar disc arthroplasty
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Ocrelizumab for relapsing-remitting multiple sclerosis
2014	Blue Cross Blue Shield Association (BCBS)	Intra-articular hyaluronic acid for osteoarthritis of the knee
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Eplerenone for NYHA functional class III/ IV heart failure and left-ventricular systolic dysfunction: clinical and cost-effectiveness
2014	National Institute for Health and Care Excellence (NICE)	Endoscopic radiofrequency ablation for Barrett's oesophagus with low-grade dysplasia or no dysplasia. NICE interventional procedures guidance 496
2014	Health Quality Ontario (HQO)	Frequency of testing for dyslipidemia: a systematic review and budget impact analysis
2014	Blue Cross Blue Shield Association (BCBS)	CYP2D6 pharmacogenomics of tamoxifen treatment
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Ocrelizumab for primary progressive multiple sclerosis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Off-label use of 5HT3 antagonists: clinical evidence and guidelines
2014	National Institute for Health and Care Excellence (NICE)	Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagus. NICE interventional procedures guidance 497
2014	Health Quality Ontario (HQO)	Multiple intravenous infusions phases 2a and 2b: OHTAC recommendation
2014	Blue Cross Blue Shield Association (BCBS)	Transcranial magnetic stimulation for depression
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Curelator Headache™ digital platform for adults with migraine
2014	Blue Cross Blue Shield Association (BCBS)	Fecal DNA analysis for colorectal cancer screening
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nebulized Lidocaine for patients with nasal trauma: clinical effectiveness and guidelines
2014	National Institute for Health and Care Excellence (NICE)	Powered microdebrider turbinoplasty for inferior turbinate hypertrophy. NICE interventional procedures guidance 498
2014	Blue Cross Blue Shield Association (BCBS)	Percutaneous tibial nerve stimulation for the treatment of voiding dysfunction
2014	NIHR Horizon Scanning Centre (NIHR HSC)	SensiumVitals® vital signs monitoring patch
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Fluticasone furoate/vilanterol (as trifenatate) (Relvar® Ellipta®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ankle braces for the prevention of injury in sport: clinical effectiveness
2014	National Institute for Health and Care Excellence (NICE)	Endoscopic saphenous vein harvest for coronary artery bypass grafting. NICE interventional procedures guidance 494
2014	Blue Cross Blue Shield Association (BCBS)	Gene expression analysis for prostate cancer management
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Peramivir for acute uncomplicated influenza in adults
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Velaglucerase alfa
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Ketorolac for pain management: a review of the clinical evidence
2014	National Institute for Health and Care Excellence (NICE)	Radiofrequency tissue reduction for turbinate hypertrophy. NICE interventional procedures guidance 495
2014	Blue Cross Blue Shield Association (BCBS)	Myocardial sympathetic innervation imaging in heart failure
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Ivacaftor (Kalydeco) for an additional 8 mutations in cystic fibrosis (licence extension)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Emtricitabine/rilpivirine/tenofovir disoproxil (as fumarate) (Eviplera®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Cystoscopy for the diagnosis of patients with urological issues: guidelines
2014	National Institute for Health and Care Excellence (NICE)	Teriflunomide for treating relapsing–remitting multiple sclerosis. NICE technology appraisal guidance 303
2014	National Institute for Health and Care Excellence (NICE)	Gastroelectrical stimulation for gastroparesis. NICE interventional procedures guidance 489
2014	Blue Cross Blue Shield Association (BCBS)	Artificial intervertebral disc arthroplasty for treatment of degenerative disc disease of the cervical spine
2014	NIHR Horizon Scanning Centre (NIHR HSC)	InterVapor® System for the treatment of severe emphysema
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Imatinib (Glivec®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dioctyl sulfosuccinate or docusate (calcium or sodium) for the prevention or management of constipation: a review of the clinical effectiveness
2014	National Institute for Health and Care Excellence (NICE)	Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hip. NICE technology appraisal guidance 304
2014	National Institute for Health and Care Excellence (NICE)	Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limb. NICE interventional procedures guidance 487
2014	Blue Cross Blue Shield Association (BCBS)	Artificial pancreas device systems
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Ivermectin 1% topical cream for papulopustular rosacea
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Eltrombopag (Revolade®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Interferon-free regimens for chronic hepatitis C genotype 1
2014	National Institute for Health and Care Excellence (NICE)	Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion. NICE technology appraisal guidance 305
2014	National Institute for Health and Care Excellence (NICE)	Arthroscopic radiofrequency chondroplasty for discrete chondral defects of the knee. NICE interventional procedures guidance 493
2014	NIHR Health Technology Assessment programme	Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds
2014	Blue Cross Blue Shield Association (BCBS)	Special report: screening asymptomatic women with dense breasts and normal mammograms for breast cancer
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Thymosin beta-4 for epidermolysis bullosa
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Lipegfilgrastim (Lonquex®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Obesity interventions delivered in primary care for patients with diabetes: a review of clinical effectiveness
2014	National Institute for Health and Care Excellence (NICE)	Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B-cell lymphoma. NICE technology appraisal guidance 306
2014	National Institute for Health and Care Excellence (NICE)	Extracorporeal membrane oxygenation (ECMO) for acute heart failure in adults. NICE interventional procedures guidance 482
2014	NIHR Health Technology Assessment programme	European network for Health Technology Assessment Joint Action (EUnetHTA JA): a process evaluation performed by questionnaires and documentary analysis
2014	NIHR Health Technology Assessment programme	The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials
2014	NIHR Horizon Scanning Centre (NIHR HSC)	CelluTome™ epidermal harvesting system for autologous skin grafting
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Delta-9-tetrahydrocannabinol/cannabidiol (Sativex®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Interferon-free regimens for genotype 1 chronic hepatitis C: a review of the clinical evidence and cost-effectiveness
2014	National Institute for Health and Care Excellence (NICE)	Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy. NICE technology appraisal guidance 307
2014	National Institute for Health and Care Excellence (NICE)	Insertion of a magnetic bead band for faecal incontinence. NICE interventional procedures guidance 483
2014	NIHR Health Technology Assessment programme	Maximising the value of combining qualitative research and randomised controlled trials in health research: the QUAlitative Research in Trials (QUART) study a mixed methods study
2014	NIHR Health Technology Assessment programme	Coronary artery bypass grafting in high-RISk patients randomised to off- or on-Pump surgery: a randomised controlled trial (the CRISP trial)
2014	HAYES, Inc.	Antimicrobial central venous catheters
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Fluticasone furoate/vilanterol (as trifenatate) (Relvar® Ellipta®)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long-term 5HT3 antagonist use for schizophrenia: clinical evidence and guidelines
2014	National Institute for Health and Care Excellence (NICE)	Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitis. NICE technology appraisal guidance 308
2014	National Institute for Health and Care Excellence (NICE)	Transoral carbon dioxide laser surgery for primary treatment of oropharyngeal malignancy. NICE interventional procedures guidance 484
2014	NIHR Horizon Scanning Centre (NIHR HSC)	Dinutuximab (Unituxin) for high risk neuroblastoma – maintenance therapy